Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Biankin, A.V., J.G. Kench, F.P. Dijkman, S.A. Biankin, and S.M. Henshall. 2003. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology. 35:14–24.
Blaser, M. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 102:720–727.
Blaser, M., and J. Parsonnet. 1994. Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest. 94:4–8.
Borch, K., H. Renvall, and G. Liedberg. 1985. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 88:638–648.
Brito, M.J., M.I. Filipe, J. Linehan, and J. Jankowski. 1995. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: biological and clinical variables. Int J Cancer. 60:27–32.
Burdick, J.S., E. Chung, G. Tanner, M. Sun, J.E. Paciga, J.Q. Cheng, K. Washington, J.R. Goldenring, and R.J. Coffey. 2000. Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 343:1697–1701.
Cameron, A.J., C.T. Lomboy, M. Pera, and H.A. Carpenter. 1995. Adenocarcinoma of the esoph-agogastric junction and Barrett's esophagus. Gastroenterology. 109:1541–1546.
Cameron, A.J., B.J. Ott, and W.S. Payne. 1985. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. New Engl J Med. 313:857–859.
Canfield, V.A., A.B. West, J.R. Goldenring, and R. Levenson. 1996. Targeted ablation of parietal cells in transgenic mice. Proc Natl Acad Sci USA. 93(6):2431–2435.
Coffey, R.J., R. Derynck, J.N. Wilcox, T.S. Bringman, A.S. Goustin, H.L. Moses, and M.R. Pittelkow. 1987. Production and auto-induction of TGF alpha in human keratinocytes. Nature. 328:817–820.
Correa, P. 1988. A human model of gastric carcinogenesis. Cancer Res. 48:3554–3560.
Courtois-Coutry, N., D. Rousch, V. Rajendran, J.B. McCarthy, J. Geibel, M. Kashgarian, and M.J. Caplan. 1997. A tyrosine-based signal targets H/K-ATPase to a regulated compartment and is required for the cessation of gastric acid secretion. Cell. 90:501–510.
Dempsey, P.J., J.R. Goldenring, C.J. Soroka, I.M. Modlin, R.W. McClure, C.D. Lind, D.A. Ahlquist, M.R. Pittlekow, D.C. Lee, E.P. Sandgren, D.L. Page, and R.J. Coffey. 1992. Possible role of TGFa in the pathogenesis of Menetrier's disease: supportive evidence from humans and transgenic mice. Gastroenterology. 103:1950–1963.
Dhar, D.K., T.C. Wang, R. Maruyama, J. Udagawa, H. Kubota, T. Fuji, M. Tachibana, T. Ono, H. Otani, and N. Nagasue. 2003. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest. 83:1343–1352.
El-Zimaity, H.M.T., H. Ota, D.Y. Graham, T. Akamatsu, and T. Katsuyama. 2002. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 94:1428–1436.
Filipe, M.I., N. Munoz, I. Matko, I. Kato, V. Pompe-Kirn, A. Juersek, S. Teuchmann, M. Benz, and T. Prijon. 1994. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 57:324–329.
Fox, J.G., M. Blanco, J.C. Murphy, N.S. Taylor, A. Lee, Z. Kabok, and J. Pappo. 1993. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun. 61:2309–2315.
Fox, J.G., X. Li, R.J. Cahill, K. Andrutis, A.K. Rustgi, R. Odze, and T.C. Wang. 1996. Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology. 110:155–166.
Fox, J.G., T.C. Wang, A.B. Rogers, T. Poutahidis, Z. Ge, N. Taylor, C.A. Dangler, D.A. Israel, U. Krishna, K. Gaus, and R.M. Peek, Jr. 2003. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 124:1879–1890.
Goldenring, J.R., and S. Nomura. 2006. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol. 291:G999–1004.
Goldenring, J.R., G.S. Ray, R.J. Coffey, P.C. Meunier, P.J. Haley, T.B. Barnes, and B.D. Car. 2000. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 118:1080–1093.
Halldorsdottir, A.M., M. Sigurdardottir, J.G. Jonasson, M. Oddsdottir, J. Magnusson, J.R. Lee, and J.R. Goldenring. 2003. Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci. 48:431–441.
Hattori, T. 1986. Development of adenocarcinomas in the stomach. Cancer. 57:1528–1534.
Hattori, T., and S. Fujita. 1979. Tritiated thymidine autoradiographic study on histogenesis and spreading of intestinal metaplasia in human stomach. Pathol Res Pract. 164:224–237.
Hattori, T., B. Helpap, and P. Gedigk. 1982. The morphology and cell kinetics of pseudopyloric glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 39:31–40.
Houghton, J., C. Stoicov, S. Nomura, J. Carlson, H. Li, A.B. Rogers, J.G. Fox, J.R. Goldenring, and T.C. Wang. 2004. Gastric cancer originating from bone marrow derived cells. Science. 306:1568–1571.
Katz, J.P., N. Perreault, B.G. Goldstein, L. Actman, S.R. McNally, D.G. Silberg, E.E. Furth, and K.H. Kaestner. 2005. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 128:935–945.
Kirchner, T., S. Muller, T. Hattori, K. Mukaisyo, T. Papadopoulos, T. Brabletz, and A. Jung. 2001. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch. 439:512–522.
Konda, Y., H. Kamimura, H. Yokota, N. Hayashi, K. Sugano, and T. Takeuchi. 1999. Gastrin stimulates the growth of gastric pit with less-differentiated features. Am J Physiol. 277: G773–784.
Leys, C.M., S. Nomura, E. Rudzinski, M. Kaminishi, E. Montgomery, M.K. Washington, and J.R. Goldenring. 2006. Expression of Pdx-1 in human gastric metaplasia and gastric adenocar-cinoma. Hum Pathol. 37:1162–1168.
Li, Q., S.M. Karam, and J.I. Gordon. 1996. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 271:3671–3676.
Lopez-Diaz, L., K.L. Hinkle, R.N. Jain, Y. Zavros, C.S. Brunkan, T. Keeley, K.A. Eaton, J.L. Merchant, C.S. Chew, and L.C. Samuelson. 2006. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol. 290: G970–979.
Marshall, A.C., F. Alderuccio, K. Murphy, and B.H. Toh. 2005. Mechanisms of gastric mucosal cell loss in autoimmune gastritis. Int Rev Immunol. 24:123–134.
Means, A.L., I.M. Meszoely, K. Suzuki, Y. Miyamoto, A.K. Rustgi, R.J. Coffey, Jr., C.V. Wright, D.A. Stoffers, and S.D. Leach. 2005. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development.132:3767–3776.
Mutoh, H., Y. Hakamata, K. Sato, A. Eda, I. Yanaka, S. Honda, H. Osawa, Y. Kaneko, and K. Sugano. 2002. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 294:470–479.
Nam, K.T., A. Varro, R.J. Coffey, and J.R. Goldenring. 2007. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology. 132:1804–1819.
Nomura, S., S.H. Settle, C. Leys, A.L. Means, R.M. Peek, Jr., S.D. Leach, C.V.E. Wright, R.J. Coffey, and J.R. Goldenring. 2005. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFa overexpression. Gastroenterology. 128:1292–1305.
Nomura, S., H. Yamaguchi, T.C. Wang, J.R. Lee, and J.R. Goldenring. 2004. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol. 288:G362–G375.
Nozaki, K., M. Ogawa, J.A. Williams, B.J. LaFleur, V. Ng, R.I. Drapkin, J.C. Mills, S.F. Konieczny, S. Nomura, and J.R. Goldenring. 2008. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology. 134(2):511–522.
Ogawa, T., K. Maeda, S. Tonai, T. Kobayashi, T. Watanabe, and S. Okabe. 2003. Utilization of knockout mice to examine the potential role of gastric histamine H2-receptors in Menetrier's disease. J Pharmacol Sci. 91:61–70.
Ogawa, M., S. Nomura, B.D. Car, and J.R. Goldenring. 2006a. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777. Dig Dis Sci. 51:431–439.
Ogawa, M., S. Nomura, A. Varro, T.C. Wang, and J.R. Goldenring. 2006b. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy. Am J Physiol Gastrointest Liver Physiol. 290:G793–804.
Ormand, J.E., N.J. Talley, R.G. Shorter, C.R. Conley, H.A. Carpenter, A. Fich, W.R. Wilson, and S.F. Phillips. 1991. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 36:142–145.
Oshima, M., H. Oshima, A. Matsunaga, and M.M. Taketo. 2005. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 trans-genic mice. Cancer Res. 65:9147–9151.
Parsonnet, J., G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H. Vogelman, N. Orentreich, and R.K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric cancer. New Engl J Med. 325:1127–1131.
Peura, D.A. 1997. The report of the Digestive Health Initiative international update conference on Helicobacter pylori. Gastroenterology. 113:S4–S8.
Pisani, P., D.M. Parkin, F. Bray, and J. Ferlay. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:18–29.
Rembacken, B., T. Fujii, and H. Kondo. 2001. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract Res Clin Gastroenterol. 15:317–336.
Schmidt, P.H., J.R. Lee, V. Joshi, R.J. Playford, R. Poulsom, N.A. Wright, and J.R. Goldenring. 1999. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 79:639–646.
Sharp, R., M.W. Babyatsky, H. Takagi, S. Tagerud, T.C. Wang, D.E. Bockman, S.E. Brand, and G. Merlino. 1995. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development. 121:149–161.
Silberg, D.G., J. Sullivan, E. Kang, G.P. Swain, J. Moffett, N.J. Sund, S.D. Sackett, and K.H. Kaestner. 2002. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 122:689–696.
Takizawa, T., and M. Koike. 1998. Minute gastri carcinoma from pathomorphological aspect— reconsideration concerning histogenesis of gastric carcinomas. Stomach Intestine. 23:791–800.
Wainess, R.M., J.B. Dimick, G.R. Upchurch, Jr., J.A. Cowan, and M.W. Mulholland. 2003. Epidemiology of surgically treated gastric cancer in the United States, 1988–2000. J Gastrointest Surg. 7:879–883.
Wang, T.C., C.A. Dangler, D. Chen, J.R. Goldenring, T. Koh, R. Raychowdhury, R.J. Coffey, S. Ito, A. Varro, G.J. Dockray, and J.G. Fox. 2000. Synergistic interaction between hypergas-trinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 118:36–47.
Wang, T.C., J.R. Goldenring, C. Dangler, S. Ito, A. Mueller, W.K. Jeon, T.J. Koh, and J.G. Fox. 1998. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 114:675–689.
Wolfsen, H.C., H.A. Carpenter, and N.J. Talley. 1993. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 104:1310–1319.
Wright, N.A., C. Pike, and G. Elia. 1990. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:82–85.
Xia, H.H., J.S. Kalantar, N.J. Talley, J.M. Wyatt, S. Adams, K. Cheung, and H.M. Mitchell. 2000.Antral-type mucosa in the gastric incisura, body and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia. Am J Gastroenterol. 95:114–121.
Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2001. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance post-gastrectomy biopsies. Dig Dis Sci. 47:573–578.
Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2002. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest. 82:1045–1052.
Yoshizawa, N., Y. Takenaka, H. Yamaguchi, T. Tetsuya, H. Tanaka, M. Tatematsu, S. Nomura, J.R. Goldenring, and M. Kaminishi. 2007. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest. 87:1265–1276.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Goldenring, J.R., Nomura, S. (2009). Insights into the Development of Preneoplastic Metaplasia: Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy. In: Wang, T.C., Fox, J.G., Giraud, A.S. (eds) The Biology of Gastric Cancers. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69182-4_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-69182-4_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69181-7
Online ISBN: 978-0-387-69182-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)